From May 21-26, for the first time, the Davos Forum will feature The House of Psychedelics. Here's why that matters for the psychedelics industry. The post Psychedelic Capitalism Takes a… Read More
I finally caught the bug, and after a mild bout with the Coronavirus, I ate 3.7 grams of mushrooms during my final weekend of quarantine. The post COVID-19 on Mushrooms:… Read More
Our resident psychedelic investor explains a handful of important metrics to study when analyzing and comparing psychedelic stocks. The post Comparing MindMed, Atai Life Sciences, Compass Pathways: A Psychedelic Stock… Read More
The history of MDMA is fascinating, and it is still being written. The post A Brief History of MDMA: From the CIA to Raves to Psychedelic Therapy appeared first on… Read More
This week in psychedelic business news: Beckley Retreats set launch; another shark swims into the psychedelics industry; and MindMed shares promising LSD study results. The post Psychedelic Business Spotlight –… Read More
This week on the Psychedelic Spotlight podcast, we talk with Sam Chapman. Sam is a resident of Portland, Oregon, he was the Campaign Manager for Oregon Measure 109, and is… Read More
Psilocybin fosters greater connections between different regions of the brain in depressed people, freeing them up from long-held patterns of rumination and excessive self-focus, according to a new study. Read More
A new paper provides a scientific framework to help shape the rollout of a program in Oregon that will legally permit the use of psilocybin for therapeutic reasons. Read More
A new study addresses the question of whether psychedelics might change the attribution of consciousness to a range of living and nonliving things. Read More
As Oregon embarks on a voter-approved initiative to permit psychoactive mushrooms in clinical use, a new systematic evidence review reveals a lack of scientific research describing the interactions between widely… Read More
Psychedelics may find new, legitimate roles in treatment for anxiety, depression, stress disorders, addiction, and other mental and behavioral health problems. But ensuring they do requires developing rigorous, standardized methods… Read More
In the world's largest study on psychedelics and the brain, a team of researchers have shown how drug-induced changes in subjective awareness are anatomically rooted in specific neurotransmitter receptor systems. Read More
A clinic in Montreal received Health Canada's approval on May 5 to care for a patient who had undergone several unsuccessful treatments for depression. Read More
Health Canada will now allow physicians to request restricted psychedelic drugs for patients as part of their psychotherapy through its Special Access Program. Read More
The study followed more than 8,000 people around the world, half of whom were microdosing with psychedelics like magic mushrooms. Read More
The field of psychedelic research for mental health is attracting growing interest from the scientific and medical communities. Read More
The stress of COVID-19 may be contributing to a boom in psychedelic consumption because of the mental health crisis the pandemic has created. Read More
A man died at the porn actor's home in Spain last year after inhaling 5-MeO-DMT, a hallucinatory drug made from toad venom, police say. Read More
From May 21-26, for the first time, the Davos Forum will feature The House of Psychedelics. Here's why that matters for the psychedelics industry. The post Psychedelic Capitalism Takes a… Read More
I finally caught the bug, and after a mild bout with the Coronavirus, I ate 3.7 grams of mushrooms during my final weekend of quarantine. The post COVID-19 on Mushrooms:… Read More
Our resident psychedelic investor explains a handful of important metrics to study when analyzing and comparing psychedelic stocks. The post Comparing MindMed, Atai Life Sciences, Compass Pathways: A Psychedelic Stock… Read More
The history of MDMA is fascinating, and it is still being written. The post A Brief History of MDMA: From the CIA to Raves to Psychedelic Therapy appeared first on… Read More
This week in psychedelic business news: Beckley Retreats set launch; another shark swims into the psychedelics industry; and MindMed shares promising LSD study results. The post Psychedelic Business Spotlight –… Read More
This week on the Psychedelic Spotlight podcast, we talk with Sam Chapman. Sam is a resident of Portland, Oregon, he was the Campaign Manager for Oregon Measure 109, and is… Read More
Growing interest in psychedelics has spurred new research decades after hallucinogenics were tested in Saskatchewan in the 1950s. And an unassuming common fish is proving a useful test subject. Read More
It may have ‘worked’ for Winston Churchill. That doesn’t mean it will work for you. Read More
Microdosing involves taking a low dose of a psychedelic drug to enhance performance, or reduce symptoms of stress and anxiety. Here’s what our research shows. Read More
Psychedelics use is on the rise and it’s partly due to a wellbeing rebrand. Read More
In a new research study, more than 900 people from around the world explain the challenges and benefits of microdosing LSD and psilocybin-containing mushrooms. Read More
According to new research, individuals who take small regular doses of psychedelics such as LSD and psilocybin mushrooms score higher on mental health, well-being and creativity. Read More
The article A Deeper Look at Affordability, Insurance, and Access was originally published on Microdose. One of the biggest concerns in the psychedelic industry is affordability. Questions about translating psychedelic… Read More
The article MindMed Releases Phase 1 Trial Results For Opioid Addiction was originally published on Microdose. Way back in 2019, before most of us knew what a shroom stock was,… Read More
The article Albert Labs Granted Health Canada Licence was originally published on Microdose. Albert Labs Granted Health Canada Licence NEWS PROVIDED BY Albert Labs International Corp. May 16, 2022,… Read More
The article Psychedelics and Mindfulness: The Future of Mental Health? was originally published on Microdose. Throughout history, groups, cultures, religions, and spiritual traditions, worldwide, have looked to breathwork and the… Read More
The article MindMed Prepares to Raise Up to $100M in Capital was originally published on Microdose. Earlier this month we reported that MindMed had filed a prospectus with the SEC for… Read More
The article Microdose’s Deal Board Helps Democratize Psychedelic Investing was originally published on Microdose. Powered by Mission Club, the Deal Board allows Psychedelic Capital virtual event attendees the ability to… Read More
This is a guest blog post from Tim Glowik, a trauma informed and somatics informed strength and movement coach. One of the ways I am personally interested in using microdosing… Read More
This is a guest blog post from Brittany Lillegard, certified yoga teacher, Wim Hof Instructor, and microdosing coach here at Microdosing Institute. As its own practice, microdosing can have a… Read More
Our community member Maaike Boere shared her microdosing experience with us. She has had positive results for her PMS symptoms and much more. Thanks so much, Maaike for speaking out… Read More
For a few months now, I have had the pleasure of guiding and coaching Selah Sue on her microdosing journey. She shared her experience in the leading Belgian newspaper De… Read More
Let’s face it, microdosing doesn’t always work. When we started asking people about their experiences with microdosing back in 2016, we often heard: “It doesn’t work for me*”, or “I… Read More
This is a guest blog post from Francesca Annenberg, an embodied eating disorder coach and a specialist in our microdosing coaching network. Francesca has used psychedelics, both in micro and… Read More
RSS Error: WP HTTP Error: cURL error 28: Operation timed out after 10000 milliseconds with 0 bytes received
Disclaimer
Neurodose utilizes legal psychedelic analogues to create microdosing kits and other products for research purposes for independent labs, chemists and researchers. Our products are not sold for human consumption or veterinarian use.
